Apr 26,2022

Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes

The objective of the present review is to provide practical insights to quick interpretation of patient-centered metrics based on flash glucose monitoring data, as well as showing some visual examples of common clinical situations and giving practical recommendations for their management.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Apr 26,2022

BD Named to Forbes' 2022 List of Best Employers for Diversity

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been recognized by Forbes as one of the top employers in the U.S. for diversity.

View Analyst & Ambassador Comments
Go to original news
Apr 27,2022

DarioHealth Presents New Clinical Research Demonstrating Improved Outcomes for Participants Using a Single Integrated Digital Solution to Manage Multiple Chronic Conditions

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced the publication of a retrospective, real-world study demonstrating the impact of managing diabetes and weight together on a single digital platform at the Advanced Technologies and Treatments for Diabetes (ATTD) Conference being held April 27th – 30th in Barcelona and online.

CLINICAL STUDY

#dtx

View Analyst & Ambassador Comments
Go to original news
Apr 27,2022

Abbott Diabetes Care, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership For People With Diabetes

Abbott Diabetes Care, CamDiab and Ypsomed today announced that they are partnering to develop and commercialize an integrated automated insulin delivery (AID) system to help lessen the burden of round-the-clock diabetes management for people with diabetes. The initial focus of the partnership will be in European countries. The new integrated AID system is being designed to connect Abbott's FreeStyle Libre 3 sensor to CamDiab's CamAPS FX mobile app, which connects with Ypsomed's mylife YpsoPump – creating an automated process to deliver insulin based on real-time glucose data.

COLLABORATION PARTNERSHIP

#connected device

#cgm

#closed loop

View Analyst & Ambassador Comments
Go to original news
Apr 27,2022

New Studies Demonstrate Clinical Benefits of Patient- and Provider-Supportive Technology in Diabetes Management

LifeScan studies presented at the 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) examine how app-based solutions can help improve glycemic control, assist with weight loss and help with patient-provider connection during the pandemic.

CLINICAL STUDY

#bgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Apr 27,2022

Glooko adds former Eli Lilly exec to its board of directors

Diabetes management technology developer Glooko announced today that it appointed Alfonso “Chito” Zulueta to its board of directors. Zulueta joins Glooko’s board, having spent more than 30 years with Eli Lilly and Co., serving as a senior executive across an array of global business and commercial units.

View Analyst & Ambassador Comments
Go to original news
Apr 27,2022

Study shows sustained improvements with Medtronic’s MiniMed 780G with Guardian 4

Medtronic (NYSE:MDT) announced today that the extended study phase of its MiniMed 780G insulin pump system produced positive data. Fridley, Minnesota-based Medtronic presented new data from the study of MiniMed 780G with the no-calibration, non-adjunctive Guardian 4 sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) Conference in Barcelona.

CLINICAL STUDY

#closed loop

View Analyst & Ambassador Comments
Go to original news
Apr 27,2022

Insulet Presents New Omnipod® 5 System Data for Type 1 and Type 2 Diabetes

Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today presented new Omnipod® 5 Automated Insulin Delivery (AID) System study results in type 2 diabetes and other clinical data in type 1 diabetes at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Barcelona, Spain , and online.

CLINICAL STUDY

#insulin pump

#closed loop

View Analyst & Ambassador Comments
Go to original news
Apr 27,2022

Real-World Evidence Confirms Immediate and Ongoing Performance of the t:slim X2 Insulin Pump with Control-IQ Technology in Children and Adults

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced real-world data confirming that use of the t:slim X2™ insulin pump with Control-IQ® advanced hybrid closed-loop technology resulted in immediate and ongoing improvements in glycemic control, quality of life outcomes, and user-reported reduced burden of diabetes management.

CLINICAL STUDY

#insulin pump

#closed loop

View Analyst & Ambassador Comments
Go to original news
Apr 27,2022

Welldoc Presents Data Indicating Continuous Glucose Monitoring (CGM) Combined with a Digital Health Solution Leads to Significant Improvements in Glycemic Outcomes

Welldoc®, a digital health leader revolutionizing chronic care, today announced the presentation of data at the 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), evaluating how the combination of real-time CGM (rtCGM) with a digital health solution impacts glucose control for individuals with Type 2 diabetes not treated with insulin.

CLINICAL STUDY

#cgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES